Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Atherosclerosis. 2017 Sep 9;265:231–241. doi: 10.1016/j.atherosclerosis.2017.09.008

Figure 5.

Figure 5

The effects of TLR4 blocking and CD36 inhibition on IL-6 secretion by HAECs treated with LPS, PA or LPS plus PA.

HAECs were treated with 0.5 ng/ml of LPS, 100 μM of PA or LPS plus PA for 24 h or 40 h in the presence or absence of neutralizing TLR4 antibody (A and B) or SSO (C and D). After the treatment, IL-6 in culture medium was quantified using ELISA. The data (mean ± SD) presented are representative of 3 experiments with similar results.